NovoCure Ltd — Director's Dealing 2024

Jun 7, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2024-06-05

Reporting Person: GROENHUYSEN WILHELMUS CM (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-06-05	Ordinary Shares	M	124373.00	$22.82	Acquired	124373.00	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-06-05	Stock Options (Right to buy)	$7.15	M	124373.00	Disposed	2027-02-21	Ordinary Shares (124373.00)	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Ordinary Shares	251235.00	Direct

Footnotes

F1: Options to buy 219,372 ordinary shares will vest in equal installments on each of February 22, 2018, 2019 and 2020, subject to the reporting person's continued employment through such dates.

F2: By The 2020 Groenhuysen Annuity Trust. Mr. Groenhuysen does not disclaim beneficial ownership.